Editorial: New products key to Big Pharma recovery

10/1/2007 | Financial Times (free content)

More than reducing work force and implementing other cost-cutting measures, drugmakers should focus on making new products to compensate for financial losses, the Financial Times writes. Companies that opted to purchase smaller firms to secure rights to new drugs have benefited from such deals, but those moves will not solve drugmakers' overall financial problems, the paper says.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC